In hepatocellular carcinoma, the PI3K pathway often undergoes aberrant activation due to PI3K gene mutations or irregularities in factors upstream of the pathway, precipitating the activation of AKT and mTOR which, in turn, stimulate growth, proliferation, and dissemination of neoplastic cells. This evidence concerns the gene MTOR and hepatocellular carcinoma.